HEALTHCARE ROYALTY PARTNERS — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Aptevo Therapeuticsaptevotherapeutics.comNASDAQ: APVOApr 2025

Aptevo Therapeutics is a clinical-stage biotechnology company developing bispecific and trispecific immunotherapies to treat cancer.

BiotechHealthtechSeattle, US

Marvin L. White(Executive Officer, Director)inDaphne Taylor(Executive Officer)Jeffrey G. Lamothe(Executive Vice President and Chief Operating Officer)

BoardJohn E Niederhuber(Director)Daniel J Abdun-Nabi(Director)Grady Grant III(Director)

Co-investorsYorkville Advisors

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.